Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease

    NEXT STORY
    Genmab Announces that Janssen has Submitted a Biologics License Application to U.S. FDA for Amivantamab in Non-small Cell Lung Cancer
    PREV STORY
    CANAQUEST ANNOUNCES MENTABINOL® A SCIENTIFIC DISCOVERY, AS PUBLISHED IN THE JOURNAL OF NEUROSCIENCE
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Achaogen to Host R&D Day Focused on Advances and Opportunities in the Treatment of Resistant Gram-Negative Infections

    SOUTH SAN FRANCISCO, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    FIT Biotech Oy Company release August 28, 2017 at 10:00 AM EET Conversion of ...

    author_avatar
    NASDAQ Market News

    FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions

    Glattbrugg, Switzerland, Nov. 28, 2016 (GLOBE NEWSWIRE) -- The updated US label for Veltassa® ...

    author_avatar
    NASDAQ Market News